This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Fragile X Syndrome". See definition (new window)
Brkanac Z. , Raskind W. H. , King B. H. (2008)
Pharmacology and genetics of autism: implications for diagnosis and treatment.
Personalized Medicine
5(6), pp. 599-607
Behavioural Brain Research
251 pp. 125-132.
Research ethics and intellectual disability: broadening the debates.
Yale Journal of Biology and Medicine
September, 86(3), pp. 303-301.
Carter M. T. , Scherer S. W. (2013)
Autism spectrum disorder in the genetics clinic: a review.
Clinical Genetics
83(5), pp. 399-407.
Ebrahimi-Fakhari D. , Sahin M. (2015)
Autism and the synapse: emerging mechanisms and mechanism-based therapies.
Current Opinion in Neurology
April, 28(2), pp. 91-102.
Sleep in subjects with autistic disorder: a neurophysiological and psychological study.
Brain and Development
22(2), pp. 88-92
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-90.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Erickson C. A. , Mullett J. , McDougle C. J. (2010)
Brief report: acamprosate in fragile X syndrome.
Journal of Autism and Developmental Disorders
40(11), pp. 1412-1416.
Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)
Open-label memantine in fragile X syndrome.
Journal of Autism and Developmental Disorders
39(12), pp. 1629-1635.
Gürkana C. K. , Hagerman R. J. (2012)
Targeted treatments in autism and fragile X syndrome.
Research in Autism Spectrum Disorders
6(4), pp. 1311-1320.
Gillberg C. et al. (1986)
Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).
Developmental Medicine and Child Neurology
28(5), pp. 624-627
Hampson D. R. , Adusei D. C. , Pacey L. K. K. (2011)
The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome.
Biochemical Pharmacology
81(9), pp. 1078-1086
Fragile X: A challenge to models of the mind and to best clinical practice.
Cortex
44(6), pp. 626-627
Hernandez R. N. et al. (2009)
Autism spectrum disorder in fragile X syndrome: A longitudinal evaluation.
American Journal of Medical Genetics
149(6), pp. 1125-1137.